Awardee OrganizationUNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
Description
Abstract Text
There have been impressive advances in understanding the molecular and cellular mechanisms of aging,
including the discovery of manipulations that delay aging and increase healthspan. Importantly, these
interventions also reduce or prevent age-related diseases. These outcomes raise the possibility that multiple
human diseases arise from a common cause – aging. The premise of this CoBRE Phase 1 is that the
mechanisms of aging and the mechanisms of age-related diseases share common cellular and molecular
processes that underlie healthspan and lifespan. An important corollary to this concept is that pre-clinical and
clinical research on age-related diseases must incorporate an understanding of the cellular/molecular changes
that occur with age in order to adequately develop treatments for age-related diseases. Here, we propose a
multidisciplinary, inter-departmental, and inter-institutional CoBRE program focused on Cellular and Molecular
Geroscience. Geroscience is a new, interdisciplinary scientific field that addresses the cellular and molecular
events that dramatically increase the risk for disease with age, create a ‘permissive milieu’ and, as a result,
disease increases exponentially. Our program has exceptional institutional support. The program is highly
innovative in that it combines mentoring of promising junior investigators (PJIs) by outstanding scientific experts
who are currently studying mechanisms of aging and by faculty investigating age-related disease in a manner
that will increase both the quantity and quality of on-going disease-related research in the context of the aging
organism. These goals will be accomplished through the mentoring of PJIs, who have faculty appointments at
OUHSC; recruiting senior investigators to the OUHSC campus; and developing the necessary infrastructure for
support of the research program. The specific aims for the program are: 1. Develop and expand institutional
biomedical research in Geroscience through the mentoring of PJIs by highly experienced, dedicated senior
investigators. 2. Enhance the infrastructure critical for expanding Geroscience research in Oklahoma. 3. Foster
collegial and collaborative relationships between CoBRE investigators and other scientists. 4. Establish
milestones and expectations that ensure the success of the program and its participants. The outcome will be
a sustainable, interdisciplinary research structure on the OUHSC campus, which will produce a new generation
of collaborative Geroscience-trained researchers and establish OUHSC as a leader in Geroscience.
Public Health Relevance Statement
Age is the single most important factor that contributes to the prevalence of most diseases. Although
interventions that have been shown to delay aging clearly have profound effects in decreasing disease,
there have been few or no studies of the underlying mechanisms. In this application, we propose a program
focused on Cellular and Molecular Geroscience to study the interactions between aging and disease and
to develop the next generation of scientists to address these issues.
!
No Sub Projects information available for 5P20GM125528-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P20GM125528-05
Patents
No Patents information available for 5P20GM125528-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P20GM125528-05
Clinical Studies
No Clinical Studies information available for 5P20GM125528-05
News and More
Related News Releases
No news release information available for 5P20GM125528-05
History
No Historical information available for 5P20GM125528-05
Similar Projects
No Similar Projects information available for 5P20GM125528-05